Results 71 to 80 of about 3,743 (224)
For those intolerant to ACE inhibitors and ARBs, what is the best therapy for reducing the risk of diabetic nephropathy? [PDF]
, 2005 Angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) are the first-line agents for reducing the risk of diabetic nephropathy.
Penmetsa, Santhi, Simmons, Michael
core
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. [PDF]
, 2015 Ischemia/reperfusion injury (IRI) represents a worldwide public health issue of increasing incidence. IRI may virtually affect all organs and tissues and is associated with significant morbidity and mortality.
Beguin, Yves +9 more
core +4 more sources
Targeting interleukin-1 signaling for renoprotection
Frontiers in ImmunologySterile inflammation with ensuing immune-mediated kidney damage has been implicated in pathophysiology of acute and chronic kidney diseases. Disinhibition of interleukin 1 (IL-1) signaling triggers local inflammation of renal tissue and may initiate or ...
Daria Bogdanova +6 more
doaj +1 more source
Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.ABSTRACT Background Hemorrhagic cystitis (HC) is a frequent and potentially severe complication following hematopoietic stem cell transplantation (HSCT) in children. It significantly affects the quality of life and prolongs hospitalization. Despite its frequency, no standardized management guidelines exist.
Pauline Mazilier +8 more
wiley +1 more source
Исследование показателей центральной гемодинамики и сосудистой ригидности у больных с хронической болезнью почек и артериальной гипертонией [PDF]
, 2017 Изучена роль показателей суточного мониторирования артериального давления в оценке центрального давления в аорте и жесткости сосудистой стенки у пациентов с хронической болезнью почек 3 стадии как в сочетании с артериальной гипертонией 2-3 степени, так и
Аджиева, И. А. +2 more
core +1 more source
Kidney transplantation in children [PDF]
, 2014 Transplantation in children with kidney failure once presented many technical, immunologic, and logistic problems that led to worse patient and allograft survival, as compared with adults.
Dharnidharka, Vikas R +2 more
core +2 more sources
Clinical Transplantation, Volume 39, Issue 12, December 2025.ABSTRACT Background Chronic kidney disease (CKD) is a common but poorly characterized complication in heart transplant (HT) recipients due to limited use of renal damage markers, such as albuminuria. Our aim is to determine CKD prevalence based on the Kidney Disease Improving Global Outcomes (KDIGO) criteria, assess CKD risk stratification according ...
Pedro Caravaca‐Pérez +11 more
wiley +1 more source
Deleting death and dialysis: Conservative care of cardio-vascular risk and kidney function loss in chronic kidney disease (CKD) [PDF]
, 2018 The uremic syndrome, which is the clinical expression of chronic kidney disease (CKD), is a complex amalgam of accelerated aging and organ dysfunctions, whereby cardio-vascular disease plays a capital role. In this narrative review, we offer a summary of
Castillo-Rodriguez, Esmeralda +5 more
core +4 more sources
Avances en la inmunosupresión para el trasplante renal. Nuevas estrategias para preservar la función renal y reducir el riesgo cardiovascular [PDF]
, 2016 The development of new immunosuppressants for renal transplantation is aimed not only at improving short-term outcomes, but also at achieving better safety, cardiovascular, and metabolic profiles and at decreasing nephrotoxicity.
Bestard Matamoros, Oriol +7 more
core +1 more source
Гинекология, 2013 Various forms of vitamin В6 (pyridoxine, pyridoxal, pyridoxal phosphate) are endogenous co-factors of over 100 enzymes in human organism. The impact of pyrodoxine and other forms of vitamin В6 on such enzymes mediates the vitamin involvement in a wide ...
O A Gromova +5 more
doaj